Integrating plasma cell-free DNA with clinical laboratory results enhances the prediction of critically ill patients with COVID-19 at hospital admission

Clin Transl Med. 2022 Jul;12(7):e966. doi: 10.1002/ctm2.966.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Cell-Free Nucleic Acids* / genetics
  • Critical Illness
  • Hospitals
  • Humans
  • Laboratories, Clinical

Substances

  • Cell-Free Nucleic Acids